Catalyst Wire Dossier Catalyst Wire Dossier

Riliprubart

· Sanofi
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Riliprubart, covering 2026-04-13 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP [Phase 3]

See pricing